L-type calcium channel blocker increases vegf concentrations in retinal cells and human serum

HIGHLIGHTS

• who: Anmol Kumar and colleagues from the Folkhau0308lsan Institute of Genetics, Folkhau0308lsan Research Center, Helsinki, Finland, Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland have published the research work: L-type calcium channel blocker increases VEGF concentrations in retinal cells and human serum, in the Journal: PLOS ONE of 18/05/2022
• what: The authors showed that amlodipine, an LTCCB, increases the secretion of VEGF in_vitro by cells of human retinal origin, in a time-dependent manner.
• how: The authors evaluated the risk of SDED associated . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.